Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 10/20 | 0.58 |
| ▸ | HPGD | P15428 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.58 |
| ▸ | RECQL | P46063 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.58 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27664913 | 0.90 | FTO (0.58) | FTOHPGDMAPTPRMT1RECQL | |
| SCHEMBL293820 | 0.88 | FTO (0.59) | FTOHPGDMAPTPRMT1RECQL | |
| SCHEMBL7527626 | 0.87 | FTO (0.58) | FTOHPGDMAPTPRMT1RECQL | |
| SCHEMBL7517672 | 0.87 | FTO (0.58) | FTOHPGDMAPTPRMT1RECQL | |
| SCHEMBL10900247 | 0.87 | FTO (0.52) | FTOHPGDMAPTPRMT1RECQL | |
| SCHEMBL6580619 | 0.84 | HPGD (0.58) | FTOHPGDMAPTPRMT1RECQL | |
| SCHEMBL340741 | 0.83 | HPGD (0.63) | FTOHPGDMAPTPRMT1RECQL | |
| SCHEMBL1908131 | 0.83 | HPGD (0.63) | FTOHPGDMAPTPRMT1RECQL | |
| SCHEMBL10435860 | 0.82 | HPGD (0.62) | FTOHPGDMAPTPRMT1RECQL | |
| SCHEMBL9130573 | 0.79 | HPGD (0.62) | FTOHPGDMAPTPRMT1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023192788-A1 | DEVELOPER COMPOSITION COMPRISING DIRECT DYE | L'OREAL (FR) | 2023-10-05 | — | — | WO | claimed |
| US-20230310285-A1 | DEVELOPER COMPOSITION COMPRISING DIRECT DYE | L'OREAL (FR) | 2023-10-05 | — | — | US | claimed |
| US-11561155-B2 | Heavy metal ion-hematein-complexes useful as ex vivo contrast agent for a computed tomography scanning of a biological sample, ex vivo method for investigating a biological sample, and use of the complexes | Technische Universität München (DE) | 2023-01-24 | — | — | US | claimed |
| US-20210371436-A1 | NOVEL HEAVY METAL ION-LIGAND-COMPLEXES USEFUL AS EX VIVO CONTRAST AGENT FOR A COMPUTED TOMOGRAPHY SCANNING OF A BIOLOGICAL SAMPLE, EX VIVO METHOD FOR INVESTIGATING A BIOLOGICAL SAMPLE, AND USE OF THE COMPLEXES | Technische Universität München (DE) | 2021-12-02 | — | — | US | claimed |
| US-20200271554-A1 | NOVEL HEAVY METAL ION-HEMATEIN-COMPLEXES USEFUL AS EX VIVO CONTRAST AGENT FOR A COMPUTED TOMOGRAPHY SCANNING OF A BIOLOGICAL SAMPLE, EX VIVO METHOD FOR INVESTIGATING A BIOLOGICAL SAMPLE, AND USE OF THE COMPLEXES | Technische Universität München (DE) | 2020-08-27 | — | — | US | claimed |
| EP-3694844-A1 | NOVEL HEAVY METAL ION-HEMATEIN-COMPLEXES USEFUL AS EX VIVO CONTRAST AGENT FOR A COMPUTED TOMOGRAPHY SCANNING OF A BIOLOGICAL SAMPLE, EX VIVO METHOD FOR INVESTIGATING A BIOLOGICAL SAMPLE, AND USE OF THE COMPLEXES | Technische Universität München (DE) | 2020-08-19 | — | — | EP | claimed |
| EP-3694845-A1 | NOVEL HEAVY METAL ION-LIGAND-COMPLEXES USEFUL AS EX VIVO CONTRAST AGENT FOR A COMPUTED TOMOGRAPHY SCANNING OF A BIOLOGICAL SAMPLE, EX VIVO METHOD FOR INVESTIGATING A BIOLOGICAL SAMPLE, AND USE OF THE COMPLEXES | Technische Universität München (DE) | 2020-08-19 | — | — | EP | claimed |
| WO-2019073065-A1 | NOVEL HEAVY METAL ION-LIGAND-COMPLEXES USEFUL AS EX VIVO CONTRAST AGENT FOR A COMPUTED TOMOGRAPHY SCANNING OF A BIOLOGICAL SAMPLE, EX VIVO METHOD FOR INVESTIGATING A BIOLOGICAL SAMPLE, AND USE OF THE COMPLEXES | Technische Universität München (DE) | 2019-04-18 | — | — | WO | claimed |
| WO-2019073064-A1 | NOVEL HEAVY METAL ION-HEMATEIN-COMPLEXES USEFUL AS EX VIVO CONTRAST AGENT FOR A COMPUTED TOMOGRAPHY SCANNING OF A BIOLOGICAL SAMPLE, EX VIVO METHOD FOR INVESTIGATING A BIOLOGICAL SAMPLE, AND USE OF THE COMPLEXES | Technische Universität München (DE) | 2019-04-18 | — | — | WO | claimed |
| CN-118215417-A | Antibacterial multi-layer fabric medium and preparation method thereof | 乔治华盛顿大学 | 2024-06-18 | — | — | CN | disclosed |
| WO-2024124139-A1 | METHODS AND DEVICES FOR MULTIPHOTON IMAGING AND LASER-TISSUE INTERACTIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-06-13 | — | — | WO | disclosed |
| US-11975221-B2 | Anti-microbial multilayer fabric media and method for making same | Shuai Danmeng (US) | 2024-05-07 | — | — | US | disclosed |
| US-20240041739-A1 | BIOPHOTONIC COMPOSITIONS AND METHODS FOR PROVIDING BIOPHOTONIC TREATMENT | KLOX TECHNOLOGIES INC. (CA) | 2024-02-08 | — | — | US | disclosed |
| EP-4274443-A1 | ANTI-MICROBIAL MULTILAYER FABRIC MEDIA AND METHOD FOR MAKING SAME | Shuai, Danmeng (US) | 2023-11-15 | — | — | EP | disclosed |
| US-4615878-A | Metachromatic dye sorption means for differential determination of sub-populations of lymphocytes | CYTOCOLOR INC., A CORP OF OH | 1986-10-07 | — | — | US | disclosed |
| EP-0179107-A1 | METACHROMATIC DYE SORPTION MEANS FOR DIFFERENTIAL DETERMINATION OF SUB-POPULATIONS OF LYMPHOCYTES. | KASS LAWRENCE | 1986-04-30 | — | — | EP | disclosed |
| US-4581223-A | STAINS FOR BLOOD COUNTS | CYTOCOLOR INC., A CORP OF OH | 1986-04-08 | — | — | US | disclosed |
| WO-1985005179-A1 | METACHROMATIC DYE SORPTION MEANS FOR DIFFERENTIAL DETERMINATION OF SUB-POPULATIONS OF LYMPHOCYTES | MERCK PATENT GMBH (DE) | 1985-11-21 | — | — | WO | disclosed |
| US-4500509-A | Metachromatic dye sorption and fluorescent light emmisive means for differential determination of developmental stages of neutrophilic granulocytic cells and other leukocytes | CYTOCOLOR INC., A CORP OF OH | 1985-02-19 | — | — | US | disclosed |
| US-4400370-A | Metachromatic dye sorption means for differential determination of leukocytes | CYTOCOLOR INC., A CORP OF OH | 1983-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210371436-A1 | NOVEL HEAVY METAL ION-LIGAND-COMPLEXES USEFUL AS EX VIVO CONTRAST AGENT FOR A COMPUTED TOMOGRAPHY SCANNING OF A BIOLOGICAL SAMPLE, EX VIVO METHOD FOR INVESTIGATING A BIOLOGICAL SAMPLE, AND USE OF THE COMPLEXES | EDNRB, ELANE, CD68 | FTO 3678/4885HPGD 3834/4885MAPT 3170/4885 |
| US-11561155-B2 | Heavy metal ion-hematein-complexes useful as ex vivo contrast agent for a computed tomography scanning of a biological sample, ex vivo method for investigating a biological sample, and use of the complexes | SERPINC1, CD63, CD68 | FTO 4588/4885HPGD 3139/4885MAPT 3682/4885 |
| US-20200271554-A1 | NOVEL HEAVY METAL ION-HEMATEIN-COMPLEXES USEFUL AS EX VIVO CONTRAST AGENT FOR A COMPUTED TOMOGRAPHY SCANNING OF A BIOLOGICAL SAMPLE, EX VIVO METHOD FOR INVESTIGATING A BIOLOGICAL SAMPLE, AND USE OF THE COMPLEXES | SERPINC1, CD63, CD68 | FTO 4620/4885HPGD 3314/4885MAPT 3711/4885 |
| US-20230310285-A1 | DEVELOPER COMPOSITION COMPRISING DIRECT DYE | TYR, CYB5R3, POLR1C | FTO 39/4885HPGD 506/4885MAPT 3307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.